Investment Summary

Arkea Capital and Astorg Partners Invest In ARMOR-IIMAK

On May 4, 2022, private equity firms Arkea Capital and Astorg Partners invested in chemicals company ARMOR-IIMAK

Investment Highlights
  • This is Arkea Capital’s 2nd and Astorg Partners’ 2nd transaction in the Chemicals sector.
  • This is Arkea Capital’s 83rd and Astorg Partners’ 34th transaction in France.

Investment Summary

Date 2022-05-04
Target ARMOR-IIMAK
Sector Chemicals
Investor(s) Arkea Capital
Astorg Partners
Deal Type Growth Capital

Target

ARMOR-IIMAK

Nantes, France
ARMOR-IIMAK invents, manufactures, and markets Thermal Transfer ribbons and associated services to variable information printing specialists through sustainable partnerships with a worldwide presence. ARMOR-IIMAK was founded in 1989 and is based in Nantes, France.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

Arkea Capital

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2011
PE ASSETS 1.3B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Arkéa Capital is the private equity investment arm of diversified financial services company Crédit Mutuel Arkéa. Arkéa Capital looks to make long-term investments in established, market leading companies. The Group does not have any sector preferences. Arkéa Capital does not have any sector preferences and is headquartered in Brest.


DEAL STATS #
Overall 85 of 111
Sector: Chemicals M&A 2 of 2
Type: Growth Capital M&A Deals 31 of 38
Country: France M&A 83 of 108
Year: 2022 M&A 9 of 19
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-28 Wichard Group

Thiers, France

Wichard Group manufactures marine hardware products and specialist in hot-drop forging for the medical, automotive, parachute hardware and aeronautic cutlery. Wichard Group was founded in 1919 and is based in Thiers, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-16 Rolmer

Challans, France

Rolmer is a supplier of ultra-fresh seafood products, which it sells to all supermarkets (large and medium-sized supermarkets) in France and traditional channels. Rolmer was founded in 1986 and is based in Challans, France.

Buy -
Investor

Astorg Partners

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1998
PE ASSETS 22.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Astorg Partners is a private equity firm that targets small to midcap company investments primarily in France and to a limited extent, Western Europe. Astorg Partners looks for companies valued between €400 million and €2 billion, requiring at least €15 million in equity. Areas of interest include healthcare, retail, distribution, hospitality, and professional services. Prospective transaction situations include leverage build-ups, divestitures, family transitions, and secondary buyouts. Astorg Partners was formed in 1998 and is based in Paris and has additional offices in London and Luxembourg.


DEAL STATS #
Overall 57 of 69
Sector: Chemicals M&A 2 of 2
Type: Growth Capital M&A Deals 2 of 2
Country: France M&A 34 of 36
Year: 2022 M&A 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-02 CordenPharma

Plankstadt, Germany

CordenPharma is a full-service partner in the Pharmaceutical Contract Development & Manufacturing (CDMO) of APIs, Excipients, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides, Lipids & Carbohydrates, Injectables, Highly Potent & Oncology, and Small Molecules – CordenPharma experts translate complex processes and projects at any stage of development into high-value products. CordenPharma was founded in 2006 and is based in Plankstadt, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-31 Open Health

London, United Kingdom

Open Health is an operator of multi-disciplinary health communications and market access group, operating within four core business areas: medical communications; patient and brand communications; value, informatics, and evidence; and consulting and commercialization. Open Health was founded in 2011 and is based in London, United Kingdom.

Buy -